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To the Editor,
Anti-synthetase syndrome (ASS) is a poorly-deﬁned, uncom-
mon  syndrome, and until recently was included within the
idiopathic inﬂammatory myopathies, which are characterised
by the presence of anti-synthetase antibodies (ASAb) in
the serum. ASAbs are IgG antibodies directed against the
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anzyme synthetase, which mediates the binding of RNA to
he speciﬁc amino acid, to form transfer RNA. Of the main
SAbs described in the bibliography, the ﬁrst and most com-
only found (15%–30%) is anti-Jo1, which is directed against
he synthetase that mediates binding between RNA and
istidine.1
During the 1990s, authors began to describe clinical cases
f patients with myositis, the presence of ASAbs in serum,
nd some generally common clinical characteristics that came
o be deﬁned as ASS. AAS is characterized by the asso-
iation of inﬂammatory myopathy, which is clinically as
uscle weakness; interstitial lung disease, which can lead
o acute respiratory failure of different histological patterns
bronchiolitis obliterans, interstitial inﬁltrates of predomi-
antly plasma cells and lymphocytes, and diffuse pulmonary
brosis); non-erosive inﬂammatory arthritis; the so-called
echanic’s hands, which have hyperkeratotic lesions accom-
anied by ﬁssures, hyperpigmentation, and scaling on the
alm and on the palmar and lateral surfaces of the ﬁngers;
nd other symptoms such as fever, Raynaud syndrome, and
jögren syndrome.1,2
We  present a case of a 59-year-old man, with no past
edical history of note except for an 80 pack-year smok-
ng history until 6 months before his admission. Over the
revious 2 months he had developed symptoms of arthral-
ia, myalgia, and oedema in the upper and lower limbs, with
ssociated loss of muscle strength. He also had moderate exer-
ional dyspnoea. On physical examination he had a blood
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pressure of 100/76 mmHg, oxygen saturation of 91% and mild
oedema of both lower limbs. Investigations: arterial blood
gas revealed a pH of 7.47, pCO2 35 mmHg, pO2 58 mmHg,
HCO3 25.5 mmol/L, oxygen saturation 91.5%. Haemoglobin
was 11.4 g/dL, and leukocytes and platelets were within nor-
mal  limits. Biochemistry showed a total protein of 4.7 g/dL,
albumin 2.74 g/dL, ALT 414 UI/L, AST 436 UI/L, GGT 11 UI/L,
LDH 1.443 UI/L, CK 9.906 UI/L, serum creatinine 0.6 mg/dL, and
urea 39 mg/dL. Acute phase reactants included an erythro-
cyte sedimentation rate of 37 mmHg  and CRP of 4.13 mg/dL.
On the auto-immune study we found negative ANA-IFA,
positive ANA-screening multiplex, a positive anti-Jo1/HRS Ab,
and the rest of the study was negative, with complement
values within normal limits. Urine contained dysmorphic
erythrocytes in the urinary sediment and proteinuria of
0.4 g/24 h. Imaging included chest X-ray which showed a bilat-
eral interstitial pattern conﬁrmed on chest scan (ﬁndings of
bilateral interstitial disease). Electromyography showed signs
of inﬂammatory myopathy. The muscle biopsy ﬁndings were
compatible with inﬂammatory myopathy, an immune myopa-
thy with perimysial (around miocyte) pathology (Fig. 1a).
On immunohistochemical study there was diffuse overex-
pression of MHC-1 in the membrane of the muscle ﬁbres
(Fig. 1b). Renal biopsy showed renal parenchyma with mild
mesangial expansion. IgA was present on direct immunoﬂuo-
rescence (Fig. 2a). Electron microscopy showed, as the main
abnormality, mild mesangial widening from both cells and
matrix with frequent homogeneous electron-dense deposits
(Fig. 2b). The patient received treatment with steroids at
a dose of 1 mg/kg/day and azathioprine 100 mg/day, which
was tolerated well, with clinical improvement, a reduction in
markers of muscle damage, and resolution of the interstitial
pattern.
Although the presence of ASAbs was previously considered
speciﬁc to polymyositis and dermatomyositis, during the lastE, Martinez MA, Toldos O, et al. Nefropatía mesangial y síndrome
–417.
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Fig. 1 – (a) Haematoxylin–eosin study of skeletal muscle tiss
perimysial localisation. (b) Immunohistochemical study of m
membrane of muscle ﬁbres.
Fig. 2 – (a) Immunoﬂuorescence study of renal tissue showin
electron-dense deposits in the mesangium (white arrow).
few years there has been describing a syndrome comprising
the presence of these autoantibodies along with interstitial
lung disease, arthritis, fever, hyperkeratotic lesions on the
hands (mechanic’s hands) and Raynaud’s phenomenon, which
has been called ASS. The clinical presentation varies between
pulmonary, muscle, and/or joint disease, but data on renal
involvement in this condition are very scarce.3 One excellent
French study described 14 cases of nephropathy and inﬂam-
matory myopathy (documented with biopsy), of which 3 cases
were ASS.4 Two patients had mesangial IgA nephropathy and
one patient had a membranous nephropathy. The 2 patients
with mesangial nephropathy received immunosuppressive
treatment with steroids and methotrexate, achieving com-
plete remission of renal disease. Mesangial IgA nephropathy
is the most documented glomerular disease associated with
ASS.5–7 The prognosis of such patients is usually determined
by pulmonary involvement. The optimal treatment for ASS is
based on the administration of steroids and immunosuppres-
sors, although there are other cases described that have been
treated successfully with rituximab.8
In conclusion, although inﬂammatory myopathies are
uncommon connective tissue diseases, we should look for
their co-existence in patients with renal disease. In ASS,
the most frequently-associated glomerular nephropathy is
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ith mononuclear inﬂammatory inﬁltrate with preferential
le tissue for MHC  1 (HLA) showing its overexpression in the
esangial deposits of IgA. (b) Electron microscopy showing
mesangial IgA nephropathy, which has a favourable outcome
in most cases.
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